HEDIS® Colorectal Cancer Screening Changes for 2017
In response to the June 2016 U.S. Preventive Services Task Force release of updated colorectal cancer screening recommendations, changes have been implemented for HEDIS® colorectal screening requirements. Changes include the addition of CT colonography and stool DNA testing as well as new wording to clarify that there are “two types of fecal occult blood tests (FOBT): guaiac (gFOBT) and immunochemical (FIT).”
Stool DNA testing (brand name Cologuard®) must be done every three years, while CT colonography should be performed every four years. In addition to flexible sigmoidoscopy and fecal occult blood testing, these two screening methods can be considered when a patient refuses a colonoscopy to increase compliance and quality measure rates.
When ordering Cologuard®, be sure your patient is aware of possible out-of-pocket expenses depending on their insurance coverage.